× |
|
EPIDUO (adapalene; benzoyl peroxide) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
DIBUTYL SEBACATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
GELATIN Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
EUCRISA (crisaborole) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
CARBOXYMETHYLCELLULOSE CALCIUM Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
D&C RED NO. 30 Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
CARBOMER HOMOPOLYMER TYPE B Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
RASPBERRY Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
DIMETHICONE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
CETEARETH-30 Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
DIETHYL PHTHALATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
CHLOROCRESOL Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
DEXTROSE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
ELLA (ulipristal acetate) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
DYANAVEL XR (amphetamine; amphetamine aspartate/dextroamphetamine sulfate) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
DIBASIC CALCIUM PHOSPHATE DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|